Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kataja

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 6, 2001
Steroid metabolism gene CYP17 polymorphism and the development of breast cancerK Mitrunen, N Jourenkova, V Kataja, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancerK Mitrunen, N Jourenkova, V Kataja, et al.
Anticancer Research|January 29, 2000
Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancerR Keskikuru, V Kataja, V M Kosma, et al.
Pathology, Research and Practice|October 1, 1992
Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expressionP Tosi, M Cintorino, R Santopietro, et al.
European Journal of Epidemiology|March 1, 1989
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic dataV Kataja, K Syrjänen, R Mäntyjärvi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Polymorphic catechol-O-methyltransferase gene and breast cancer riskK Mitrunen, N Jourenkova, V Kataja, et al.
BJU International|April 11, 2018
Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancerMichelle Lancee, Kari A O Tikkinen, Theo M de Reijke, et al.
Journal of Clinical Pathology|March 1, 2003
p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosisM J Pellikainen, T T Pekola, K M Ropponen, et al.
American Journal of Epidemiology|November 1, 1993
Risk factors associated with cervical human papillomavirus infections: a case-control studyV Kataja, S Syrjänen, M Yliskoski, et al.
Clinical Genetics|September 14, 2007
Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer familiesJ M Hartikainen, V Kataja, M Pirskanen, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 6, 2001
Steroid metabolism gene CYP17 polymorphism and the development of breast cancerK Mitrunen, N Jourenkova, V Kataja, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancerK Mitrunen, N Jourenkova, V Kataja, et al.
Anticancer Research|January 29, 2000
Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancerR Keskikuru, V Kataja, V M Kosma, et al.
Pathology, Research and Practice|October 1, 1992
Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expressionP Tosi, M Cintorino, R Santopietro, et al.
European Journal of Epidemiology|March 1, 1989
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic dataV Kataja, K Syrjänen, R Mäntyjärvi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Polymorphic catechol-O-methyltransferase gene and breast cancer riskK Mitrunen, N Jourenkova, V Kataja, et al.
BJU International|April 11, 2018
Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancerMichelle Lancee, Kari A O Tikkinen, Theo M de Reijke, et al.
Journal of Clinical Pathology|March 1, 2003
p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosisM J Pellikainen, T T Pekola, K M Ropponen, et al.
American Journal of Epidemiology|November 1, 1993
Risk factors associated with cervical human papillomavirus infections: a case-control studyV Kataja, S Syrjänen, M Yliskoski, et al.
Clinical Genetics|September 14, 2007
Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer familiesJ M Hartikainen, V Kataja, M Pirskanen, et al.
Pageof 6